tradmap

ARTL Earnings ARTELO BIOSCIENCES, INC.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$18 -$9 $0 2018 2019 2023 2024 2025
EPS
Net income (annual)
-$13M -$6M $0 2017 2018 2019 2020 2021 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-344% 696% 1736% 0% 2017 2018 2019 2020 2021 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$29 -$15 $0 Q2 '19 Q1 '20 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$4M -$2M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-364% 65% 493% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–21 of 21
Q2 20262026-06-30-3.112026-08-1210-Q
Q1 20262026-03-31-4.002026-05-1410-Q
FY 20252025-12-31-12.522026-02-2410-K
Q3 20252025-09-30-12.482025-11-1210-Q
Q2 20262025-06-30-29.442026-08-1210-Q
Q1 20262025-03-31-12.552026-05-1410-Q
FY 20252024-12-31-18.302026-02-2410-K
Q3 20252024-09-30-11.282025-11-1210-Q
Q2 20252024-06-30-9.172025-08-1310-Q
Q1 20252024-03-31-0.782025-05-1310-Q
FY 20242023-12-31-3.142025-03-0310-K
Q3 20242023-09-30-2.152024-11-1210-Q
Q2 20202020-02-29-0.792020-04-1310-Q
Q1 20202019-11-30-0.402020-01-1410-Q
FY 20192019-08-31-1.462019-11-2510-K
Q3 20192019-05-31-1.042019-07-1510-Q
Q2 20202019-02-28-0.722020-04-1310-Q
Q1 20202018-11-30-0.322020-01-1410-Q
FY 20192018-08-31-1.842019-11-2510-K
Q3 20192018-05-31-1.112019-07-1510-Q
Q2 20192018-02-28-0.102019-04-1510-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.